Skip to main navigation Skip to search Skip to main content

A multicenter, prospective, randomized, placebo-controlled, double-blind, parallel-group clinical trial to assess the efficacy and safety of Immune Globulin Intravenous (Human) Flebogamma 5% DIF in patients with Post-Polio Syndrome

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date02/12/15 → 02/11/26

Funding

  • Instituto Grifols S A: $211,090.84